# US 2023/0203550 A1 · Use of stereoselective transaminase in asymmetric synthesis of chiral amine

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0203550 A1
- Document ID: US20230203550A1
- Status: Published application
- Kind: A1
- Application number: 17/737,943
- Filed: 2022-05-05
- Published: 2023-06-29
- Earliest claimed: 2017-07-11
- Assignees: Abiochem Biotechnology Co., Ltd.
- Applicants: Abiochem Biotechnology Co., Ltd
- Inventors: Zhanbing CHENG; Tao ZHANG; Zhenhua Tian; Shaonan DING
- Web page: https://patentgrep.com/patent/US20230203550A1

## CPC

- C12P 13/06: Alanine; Leucine; Isoleucine; Serine; Homoserine
- C07C 209/24: by reductive alkylation of ammonia, amines or compounds having groups reducible to amino groups, with carbonyl compounds
- C07C 227/32: by stereospecific synthesis
- C07D 295/185: from aliphatic carboxylic acids
- C07D 487/04: Ortho-condensed systems
- C12N 9/1096: {transferring nitrogenous groups (2.6)}
- C12P 13/001: {Amines; Imines}
- C12P 13/04: Alpha- or beta- amino acids {(other amino acids C12P13/005)}
- C12P 17/12: containing a six-membered hetero ring
- C12P 17/14: Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
- C12P 17/182: {Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00)}
- C12Y 206/01: Transaminases (2.6.1)
- C12Y 206/01018: Beta-alanine-pyruvate transaminase (2.6.1.18)
- C07B 2200/07: Optical isomers
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)

## Abstract

Use of a stereoselective transaminase in the asymmetric synthesis of a chiral amine. In particular, provided is use of a polypeptide in the production of a chiral amine or a downstream product using a chiral amine as a precursor. Further provided is a method for producing a chiral amine, comprising culturing a strain expressing the polypeptide so as to obtain a chiral amine. Further provided are novel prochiral compounds, a chiral amine production strain and a method for constructing the chiral amine production strain. The stereoselective transaminase has a broad substrate spectrum and thus has a broad application potential in the preparation of a chiral amine.

## Claims

### Claim 1

A compound of Formula II, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof:
wherein,
R1 is selected from the group consisting of none, oxo (═O), halogen, —OH, —NH2, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C8 cycloalkyl, substituted or unsubstituted C1-C8 alkoxy, substituted and unsubstituted C3-C8 cycloalkoxy;
R2 is selected from the group consisting of none, halogen, —OH, —NH2, substituted or unsubstituted C1-C8 alkyl, substituted or unsubstituted C3-C8 cycloalkyl, substituted or unsubstituted C1-C8 alkoxy, substituted and unsubstituted C3-C8 cycloalkoxy;
X is selected from the group consisting of: C and N;
Y is selected from the group consisting of: C, N, O, and S;
wherein R2 is none when Y is O or S.

### Claim 2 (depends on 1)

The compound of claim 1, the pharmaceutically acceptable salt thereof, or the stereoisomer thereof, wherein the compound of Formula II comprises the following compounds:

### Claim 3 (depends on 1)

Use of the compound of Formula II of claim 1, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, for preparing a sitagliptin intermediate Boc-(R) amino-4-(2,4,5-trifluorophenyl) butyric acid.

### Claim 4 (depends on 3)

The use of claim 3, wherein the compound of Formula II comprises the following compounds:

### Claim 5 (depends on 1)

Use of the compound of Formula II of claim 1, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, as a prochiral carbonyl substrate for a transaminase to produce a chiral amine.

### Claim 6 (depends on 5)

The use of claim 5, wherein the chiral amine produced is compound 5a, or a pharmaceutically acceptable salt thereof:

### Claim 7 (depends on 5)

The use of claim 5, wherein the prochiral carbonyl substrate is selected from the group consisting of compounds 6-8,

### Claim 8 (depends on 5)

The use of claim 5, wherein the transaminase has the amino acid sequence set forth in SEQ ID NO: 1.
